Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial.
Ohkuma T, Zoungas S, Jun M, Lisheng L, Mancia G, Marre M, Rodgers A, Williams B, Woodward M, Chalmers J; ADVANCE Collaborative Group. Ohkuma T, et al. Among authors: chalmers j. Diabetes Obes Metab. 2020 Mar;22(3):452-457. doi: 10.1111/dom.13878. Epub 2019 Oct 30. Diabetes Obes Metab. 2020. PMID: 31486188 Clinical Trial.
Clinical implications of PROGRESS: questions and answers.
Chalmers J, Adams HP Jr, Donnan GA, Fox K, MacMahon S, Mancia G, Tzourio C. Chalmers J, et al. J Hypertens Suppl. 2003 Jun;21(5):S21-4. doi: 10.1097/00004872-200306005-00005. J Hypertens Suppl. 2003. PMID: 12953852 No abstract available.
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A, Chapman N, Woodward M, Liu LS, Colman S, Lee A, Chalmers J, MacMahon S; Perindopril Protection against Recurrent Stroke Study Collaborative Group. Rodgers A, et al. Among authors: chalmers j. J Hypertens. 2004 Mar;22(3):653-9. doi: 10.1097/00004872-200403000-00030. J Hypertens. 2004. PMID: 15076173 Clinical Trial.
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J; PROGRESS CT Substudy Investigators. Hasegawa Y, et al. Among authors: chalmers j. Hypertens Res. 2004 Mar;27(3):147-56. doi: 10.1291/hypres.27.147. Hypertens Res. 2004. PMID: 15080373 Free article. Clinical Trial.
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration. Turnbull F, et al. Among authors: chalmers j. Arch Intern Med. 2005 Jun 27;165(12):1410-9. doi: 10.1001/archinte.165.12.1410. Arch Intern Med. 2005. PMID: 15983291
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H, Hart RG, Colman S, Chalmers J, Anderson C, Rodgers A, Woodward M, MacMahon S, Neal B; PROGRESS Collaborative Group. Arima H, et al. Among authors: chalmers j. Stroke. 2005 Oct;36(10):2164-9. doi: 10.1161/01.STR.0000181115.59173.42. Epub 2005 Sep 1. Stroke. 2005. PMID: 16141420 Clinical Trial.
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C; PROGRESS MRI Substudy Investigators. Dufouil C, et al. Among authors: chalmers j. Circulation. 2005 Sep 13;112(11):1644-50. doi: 10.1161/CIRCULATIONAHA.104.501163. Epub 2005 Sep 6. Circulation. 2005. PMID: 16145004
1,978 results